EUSA Pharma To Pay $180K Over Inflated Medicare Claims

Law360, New York (March 23, 2012, 4:55 PM EDT) -- EUSA Pharma USA Inc. has agreed to pay $180,000 to resolve a former employee’s $10 million whistleblower suit accusing the pharmaceutical firm of advising doctors to submit inflated claims to Medicare for certain imaging scans, the U.S. Department of Justice said Friday.

Langhorne, Pa.-based EUSA allegedly violated the False Claims Act by telling doctors to submit extra claims for certain scans after the use of its radiopharmaceutical ProstaScint, a diagnostic scanning chemical used to detect prostate cancer, according to prosecutors, who noted that the Society of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.